Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213251216> ?p ?o ?g. }
- W4213251216 abstract "The emergence of the novel coronavirus (SARS-CoV-2) in December 2019 has generated a devastating global consequence which makes the development of a rapidly deployable, effective and safe vaccine candidate an imminent global health priority. The design of most vaccine candidates has been directed at the induction of antibody responses against the trimeric spike glycoprotein of SARS-CoV-2, a class I fusion protein that aids ACE2 (angiotensin-converting enzyme 2) receptor binding. A variety of formulations and vaccinology approaches are being pursued for targeting the spike glycoprotein, including simian and human replication-defective adenoviral vaccines, subunit protein vaccines, nucleic acid vaccines and whole-inactivated SARS-CoV-2. Here, we directed a reverse vaccinology approach towards the design of a nucleic acid (mRNA-based) vaccine candidate. The YLQPRTFLL peptide sequence (position 269-277) which was predicted to be a B cell epitope and likewise a strong binder of the HLA*A-0201 was selected for the design of the vaccine candidate, having satisfied series of antigenicity assessments. Through the codon optimization protocol, the nucleotide sequence for the vaccine candidate design was generated and targeted at the human toll-like receptor 7 (TLR7). Bioinformatics analyses showed that the sequence UACCUGCAGCCGCGUACCUUCCUGCUG exhibited a strong affinity and likewise was bound to a stable cavity in the TLR7 pocket. This study is therefore expected to contribute to the research efforts directed at securing definitive preventive measures against the SARS-CoV-2 infection." @default.
- W4213251216 created "2022-02-24" @default.
- W4213251216 creator A5001062163 @default.
- W4213251216 creator A5013747855 @default.
- W4213251216 creator A5028826634 @default.
- W4213251216 creator A5034662338 @default.
- W4213251216 creator A5068432895 @default.
- W4213251216 creator A5072432580 @default.
- W4213251216 date "2022-02-17" @default.
- W4213251216 modified "2023-09-25" @default.
- W4213251216 title "Identification of a Potential mRNA‐based Vaccine Candidate against the SARS‐CoV‐2 Spike Glycoprotein: A Reverse Vaccinology Approach" @default.
- W4213251216 cites W118179289 @default.
- W4213251216 cites W1502735160 @default.
- W4213251216 cites W1530470635 @default.
- W4213251216 cites W1760665500 @default.
- W4213251216 cites W1919748804 @default.
- W4213251216 cites W1979201508 @default.
- W4213251216 cites W1979284950 @default.
- W4213251216 cites W1981021420 @default.
- W4213251216 cites W1981106544 @default.
- W4213251216 cites W1992450378 @default.
- W4213251216 cites W1997172276 @default.
- W4213251216 cites W2000383223 @default.
- W4213251216 cites W2006877285 @default.
- W4213251216 cites W2010122910 @default.
- W4213251216 cites W2014495927 @default.
- W4213251216 cites W2014992495 @default.
- W4213251216 cites W2015057312 @default.
- W4213251216 cites W2032872978 @default.
- W4213251216 cites W2042433863 @default.
- W4213251216 cites W2044101417 @default.
- W4213251216 cites W2047534347 @default.
- W4213251216 cites W2048013101 @default.
- W4213251216 cites W2059289660 @default.
- W4213251216 cites W2062267695 @default.
- W4213251216 cites W2064079961 @default.
- W4213251216 cites W2064719064 @default.
- W4213251216 cites W2067174909 @default.
- W4213251216 cites W2070434454 @default.
- W4213251216 cites W2072180710 @default.
- W4213251216 cites W2081912151 @default.
- W4213251216 cites W2082706052 @default.
- W4213251216 cites W2092247420 @default.
- W4213251216 cites W2093221728 @default.
- W4213251216 cites W2094210850 @default.
- W4213251216 cites W2094287390 @default.
- W4213251216 cites W2096525273 @default.
- W4213251216 cites W2097874743 @default.
- W4213251216 cites W2102367710 @default.
- W4213251216 cites W2107198699 @default.
- W4213251216 cites W2117645719 @default.
- W4213251216 cites W2118619855 @default.
- W4213251216 cites W2129961630 @default.
- W4213251216 cites W2130479394 @default.
- W4213251216 cites W2132260239 @default.
- W4213251216 cites W2132629607 @default.
- W4213251216 cites W2136513422 @default.
- W4213251216 cites W2139230158 @default.
- W4213251216 cites W2144870003 @default.
- W4213251216 cites W2145878157 @default.
- W4213251216 cites W2147763501 @default.
- W4213251216 cites W2148086787 @default.
- W4213251216 cites W2148373543 @default.
- W4213251216 cites W2152770371 @default.
- W4213251216 cites W2166867592 @default.
- W4213251216 cites W2168036974 @default.
- W4213251216 cites W2271914738 @default.
- W4213251216 cites W2341963847 @default.
- W4213251216 cites W2461958429 @default.
- W4213251216 cites W2529575585 @default.
- W4213251216 cites W2573033399 @default.
- W4213251216 cites W2575633892 @default.
- W4213251216 cites W2611314002 @default.
- W4213251216 cites W2613028900 @default.
- W4213251216 cites W2615136515 @default.
- W4213251216 cites W2625571305 @default.
- W4213251216 cites W264975424 @default.
- W4213251216 cites W2682978305 @default.
- W4213251216 cites W2736048901 @default.
- W4213251216 cites W2768968558 @default.
- W4213251216 cites W2777795488 @default.
- W4213251216 cites W2782708334 @default.
- W4213251216 cites W2783653218 @default.
- W4213251216 cites W2799876761 @default.
- W4213251216 cites W2801491392 @default.
- W4213251216 cites W2923214306 @default.
- W4213251216 cites W2948622157 @default.
- W4213251216 cites W2954835418 @default.
- W4213251216 cites W2969525890 @default.
- W4213251216 cites W2981663786 @default.
- W4213251216 cites W3001118548 @default.
- W4213251216 cites W3001897055 @default.
- W4213251216 cites W3003616434 @default.
- W4213251216 cites W3004280078 @default.
- W4213251216 cites W3005844923 @default.
- W4213251216 cites W3007643904 @default.
- W4213251216 cites W3014348725 @default.
- W4213251216 cites W3026403478 @default.
- W4213251216 cites W3031718964 @default.
- W4213251216 cites W3041180919 @default.